Impaired glucose tolerance in pancreas grafted diabetic patients is due to insulin secretory defects

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 10, 2007, Pages 647-653

  Dieterle, C D ^a,b   Veitenhansl, M ^a   Gutt, B ^a   Arbogast, H ^b   Meier, G R ^a   Illner, W D ^b   Schlamp, A ^a   Seissler, J ^a   Landgraf, R ^a  

^a Medizinische Klinik Innenstadt   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Glucose tolerance; Insulin resistance; Insulin secretion; Pancreas transplantation

Indexed keywords

ARGININE; AZATHIOPRINE; CYCLOSPORIN A; GLUCOSE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ADD ON THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION;

EID: 36849078204     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-982501     Document Type: Article

References (57)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553
2. Battezzati A, Benedini S, Caldara R, Calori G, Secchi A, Pozza G, Luzi L. Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 2001; 71: 1560-1565
3. Bending JJ, Ogg CS, Viberti GC. Diabetogenic effect of cyclosporin. Br Med J (Clin Res Ed) 1987; 294: 401-402
4. Benz S, Bergt S, Obermaier R, Wiessner R, Pfeffer F, Schareck W, Hopt U T. Impairment of microcirculation in the early reperfusion period predicts the degree of graft pancreatitis in clinical pancreas transplantation. Transplantation 2001; 71: 759-763
5. Boots JM, Duijnhoven EM van, Christiaans MH, Wolffenbuttel BH, Hooff JP van. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol. 2002; 13: 221-227
6. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 2001; 44: 2107-2114
7. Braghi S, Bonifacio E, Secchi A, Carlo V Di, Pozza G, Bosi E. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 2000; 49: 218-224
8. Catena C, Soardo G, Melis A, Marchi S De, Sechi LA. Glucose metabolism in early renal failure. Am J Kidney Dis 2005; 46: 367 ; author reply 367-368.
9. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005; 54: 1-7
10. Christiansen E, Tibell A, Volund A, Rasmussen K, Groth CG, Holst JJ, Pedersen O, Christensen NJ, Madsbad S. Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation. J Clin Endocrinol Metab 1996; 81: 3972-3979
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41
12. Decode Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354: 617-621
13. Decode Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405
14. Defronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568
15. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, Defronzo RA. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994; 37: 1025-1035
16. Diem P, Abid M, Redmon JB, Sutherland DE, Robertson RP. Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 1990; 39: 534-540
17. Dieterle CD, Hierl FX, Gutt B, Arbogast H, Meier GR, Veitenhansl M, Hoffmann JN, Landgraf R. Insulin and islet autoantibodies after pancreas transplantation. 2005; 18: 1361-1365
18. Dieterle CD, Schmauss S, Veitenhansl M, Gutt B, Illner WD, Land W, Landgraf R. Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. Transplantation 2004; 77: 1561-1565
19. Douglas RG, Shaw JH. Metabolic response to sepsis and trauma. Br J Surg 1989; 76: 115-122
20. Emre S, Genyk Y, Schluger LK, Fishbein TM, Guy SR, Sheiner PA, Schwartz ME, Miller CM. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int. 2000; 13: 73-78
21. Filler G, Neuschulz I, Vollmer I, Amendt P, Hocher B. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. Nephrol Dial Transplant 2000; 15: 867-871
22. Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrom J, Leivestad T, Egeland T, Fauchald P. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979-983
23. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes 2002; 51: 2170-2178
24. Kahn SE, Prigeon RL, Macculloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672
25. Katz H, Homan M, Velosa J, Robertson P, Rizza R. Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 1991; 325: 1278-1283
26. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005; 45: 275-280
27. Landgraf R. Pancreatic transplantation and its future role in diabetes management. Diabet Med 1995; 12: 947-948
28. Landgraf R. Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 1996; 39: 1415-1424
29. Landgraf R, Nusser J, Riepl RL, Fiedler F, Illner WD, Abendroth D, Land W. Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation. Diabetologia 1991; 34: S61-S67
30. Larsen JL. Pancreas transplantation: indications and consequences. Endocr Rev 2004; 25: 919-946
31. Luzi L, Perseghin G, Regalia E, Sereni LP, Battezzati A, Baratti D, Bianchi E, Terruzzi I, Hilden H, Groop LC, Pulvirenti A, Taskinen MR, Gennari L, Mazzaferro V. Metabolic effects of liver transplantation in cirrhotic patients. J Clin Invest 1997; 99: 692-700
32. Luzi L, Secchi A, Facchini F, Battezzati A, Staudacher C, Spotti D, Castoldi R, Ferrari G, Carlo V Di, Pozza G. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 1990; 33: 549-556
33. Malaise J, Arbogast H, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Ophem D Van, Squifflet JP. Simultaneous pancreas-kidney transplantation: analysis of rejection. Transplant Proc 2005; 37: 2856-2858
34. Matsuda M, Defronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470
35. Matthews DR, Hosker JP, Rudenskia S, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
36. Morel P, Brayman KL, Goetz FC, Kendall DM, Moudry-Munns K, Chau C, Balakumar M, Stevens B, Dunn DL, Sutherland DE. Long-term metabolic function of pancreas transplants and influence of rejection episodes. Transplantation 1991; 51: 990-1000
37. Morel P, Goetz FC, Moudry-Munns K, Freier E, Sutherland DE. Long-term glucose control in patients with pancreatic transplants. Ann Intern Med 1991; 115: 694-699
38. Osei K, Henry ML, O'dorisio TM, Tesi RJ, Sommer BG, Ferguson RM. Physiological and pharmacological stimulation f pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes 1990; 39: 1235-1242
39. Ostman J, Bolinder J, Gunnarsson R, Brattstrom C, Tyden G, Wahren J, Groth CG. Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes 1989; 38 Suppl 1:88-93
40. Palmer JP, Benson JW, Walter RM, Ensinck JW. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest 1976; 58: 565-570
41. Perseghin G, Caumo A, Sereni LP, Battezzati A, Luzi L. Fasting blood sample-based assessment of insulin sensitivity in kidney- pancreastransplanted patients. Diabetes Care 2002; 25: 2207-2211
42. Petruzzo P, Andreelli F, Mcgregor B, Lefrancois N, Dawahra M, Feitosa LC, Dubernard JM, Thivolet C, Martin X. Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation. Diabetes Metab 2000; 26: 215-218
43. Petmzzo P, Laville M, Badet L, Lefrancois N, Bin-Dorel S, Chapuis F, Andreelli F, Martin X. Effect of venous drainage site on insulin action after simultaneous pancreas-kidney transplantation. Transplantation 2004; 77: 1875-1879
44. Pfeffer F, Nauck MA, Benz S, Gwodzinski A, Zink R, Busing M, Becker HD, Hopt UT. Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients. Diabetologia 1996; 39: 462-468
45. Pfeffer F, Nauck MA, Drognitz O, Benz S, Dobschuetz E Von, Hopt UT. Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation. Transplantation 2003; 76: 1427-1431
46. Piche ME, Arcand-Bosse JF, Despres JP, Perusse L, Lemieux S, Weisnagel SJ. What is a normal glucose value?. Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care 2004; 27: 2470-2477
47. Pox C, Ritzel R, Busing M, Meier JJ, Klempnauer J, Schmiegel W, Nauck MA. Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivity. Exp Clin Endocrinol Diabetes 2002; 110: 420-424
48. Pozza G, Bosi E, Secchi A, Piatti PM, Touraine JL, Gelet A, Pontiroli AE, Dubernard JM, Traeger J. Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation. Br Med J (Clin Res Ed) 1985; 291: 510-513
49. Qiao Q, Tuomilehto J, Borch-Johnsen K. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia 2003; 46 Suppl 1:M17-M21
50. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL. {beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes 2005; 54: 100-106
51. Robertson P, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas transplantation in type 1 diabetes. Diabetes Care 2004; 27 Suppl 1:S105
52. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238
53. Smets YF, Fiji JW Van Der, Frolich M, Ringers J, Fijter JW De, Lemkes HH. Insulin secretory capacity and peripheral sensitivity after pancreaskidney transplantation estimated by CIGMA. Transplant Proc 1998; 30: 623
54. Sutherland DE, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes 1989; 38 Suppl 1:85-87
55. Teuscher AU, Seaquist ER, Robertson RP. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes 1994; 43: 593-598
56. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495
57. Yki-Jarvinen H, Helve E, Koivisto VA. Hyperglycemia decreases glucose uptake in type 1 diabetes. Diabetes 1987; 36: 892-896